Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Synlogic
company
About
Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.
- Cambridge,Massachusetts,United States
- 51 - 100
- http://synlogictx.com/
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $50.01M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2014
- Number Of Employee
- 51 - 100
- Operating Status
- Active
- Stock Symbol
- nasdaq:SYBX
- Legal Name
- Synlogic, Inc.
Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases. The company's lead programs target patients with rare genetic metabolic diseases, including phenylketonuria and secondary hyperoxaluria. Synlogic is also hard at work on synthetic biotics to address more prevalent conditions, including inflammatory bowel disease, cancer, and other metabolic conditions.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
9
$321.41M
Synlogic has raised a total of
$321.41M
in funding over 2 rounds. Their latest funding was raised on
Sep 22, 2021 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 22, 2021 | Post-IPO Equity | $45M | — | — | — | Detail |
| Apr 16, 2021 | Post-IPO Equity | $30M | — | — | — | Detail |
| Jun 12, 2019 | Post-IPO Equity | $80M | 1 |
Ginkgo Bioworks
|
— | Detail |
| Jan 23, 2018 | Post-IPO Equity | $50.01M | — | — | — | Detail |
| Aug 28, 2017 | IPO | — | — | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
Synlogic has made 1 investments. Their most recent investment was on
Dec 1, 2022, when Secjur raised €5.50M.
Investors
Number of Lead Investors
Number of Investors
5
13
Synlogic is funded by 13 investors.
Ginkgo Bioworks
and Bill & Melinda Gates Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Ginkgo Bioworks
|
Yes | Post-IPO Equity |
Bill & Melinda Gates Foundation
|
Yes | Series A |
Aju IB Investment
|
— | Series C |
|
|
— | Series C |
|
|
— | Series C |
Atlas Venture
|
— | Series C |
CLI Ventures
|
— | Series C |
Daphne Teo
|
— | Series C |
|
|
— | Series C |
New Enterprise Associates
|
— | Series C |
Employee Profiles
Number of Employee Profiles
21
Synlogic has 21 current employee profiles, including
Board member Jose-Carlos Gutiérrez-Ramos
Board member
Executive
Executive
Executive
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
